Education
About Us
Working with TipRanks
Follow Us
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
Total Valuation
Tevogen Bio Holdings has a market cap or net worth of $78.66M. The enterprise value is $156.03M.
Market Cap$78.66M
Enterprise Value$156.03M
Share Statistics
Tevogen Bio Holdings has 198,689,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding198,689,930
Owned by Insiders72.08%
Owned by Institutions0.08%
Financial Efficiency
Tevogen Bio Holdings’s return on equity (ROE) is 2.06 and return on invested capital (ROIC) is 1447.31%.
Return on Equity (ROE)2.06
Return on Assets (ROA)-3.97
Return on Invested Capital (ROIC)1447.31%
Return on Capital Employed (ROCE)9.60
Revenue Per Employee0.00
Profits Per Employee-762.63K
Employee Count18
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tevogen Bio Holdings is ―. Tevogen Bio Holdings’s PEG ratio is -0.00047.
PE Ratio―
PS Ratio0.00
PB Ratio-22.64
Price to Fair Value-22.64
Price to FCF-12.59
Price to Operating Cash Flow-5.64
PEG Ratio-0.00047
Income Statement
In the last 12 months, Tevogen Bio Holdings had revenue of 0.00 and earned -10.11M in profits. Earnings per share was -0.09.
Revenue0.00
Gross Profit-403.58K
Operating Income-53.56M
Pretax Income-13.73M
Net Income-10.11M
EBITDA-13.14M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -33.69M and capital expenditures 20.00, giving a free cash flow of -33.69M billion.
Operating Cash Flow-33.69M
Free Cash Flow-33.69M
Free Cash Flow per Share-0.17
Dividends & Yields
Tevogen Bio Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.05
52-Week Price Change-61.90%
50-Day Moving Average0.49
200-Day Moving Average0.91
Relative Strength Index (RSI)43.85
Average Volume (3m)557.82K
Important Dates
Tevogen Bio Holdings upcoming earnings date is Jun 3, 2026, Before Open (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateJun 3, 2026
Ex-Dividend Date―
Financial Position
Tevogen Bio Holdings as a current ratio of 0.26, with Debt / Equity ratio of -40.00%
Current Ratio0.26
Quick Ratio0.26
Debt to Market Cap0.02
Net Debt to EBITDA-0.12
Interest Coverage Ratio-291.05
Taxes
In the past 12 months, Tevogen Bio Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tevogen Bio Holdings EV to EBITDA ratio is -11.62, with an EV/FCF ratio of -12.72.
EV to Sales0.00
EV to EBITDA-11.62
EV to Free Cash Flow-12.72
EV to Operating Cash Flow-12.72
Balance Sheet
Tevogen Bio Holdings has $1.04M in cash and marketable securities with $7.53M in debt, giving a net cash position of -$6.49M billion.
Cash & Marketable Securities$1.04M
Total Debt$7.53M
Net Cash-$6.49M
Net Cash Per Share-$0.03
Tangible Book Value Per Share-$0.05
Margins
Gross margin is -49.90%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-49.90%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tevogen Bio Holdings is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-234.46%